Changes in severity of clinical pattern of dengue infection and its management: a cross-sectional study in a tertiary care hospital
Keywords:Dengue, Mosquito, Symptoms, DSS, Treatment
Background: Dengue fever is a debilitating viral disease, transmitted by mosquitoes, and causes sudden fever, and acute pain in the joints. Aedes Aegyptus mosquitos are responsible for dengue fever. More than 500,000 people are affected by dengue fever each year. In Bangladesh, over 15,000 cases of dengue are reported each year. It is high time to take some measures to control this viral disease. The aim of the study was to investigate the clinical manifestation of dengue fever in tertiary care hospitals.
Methods: It is a prospective cross-sectional study that was carried out in the pediatric department of Dhaka medical college hospital (DMCH) over one year and was conducted with 106 patients.
Results: The finding had females dominant over males. Minimum and maximum ages were 1 and 14 respectively. All patients (106, 100%) had fever. Around one-third of the patients (34,32%) had headaches. Patients had experienced rash and vomiting. The Tourniquet test came out positive for about one-fifth of the patients (21, 19.8%). About half of the study population (50, 47.2%) had dengue fever, around two-fifth of the patients (44, 41.5%) experienced dengue hemorrhagic fever (DHF) and only 12 patients (12, 11.3%) were diagnosed with dengue shock syndrome (DSS). The majority of the patients (102, 96.22%) were given isotonic fluid. Ns1 antigen for dengue 65 cases and IgM & IgG for dengue 32 cases were positive.
Conclusions: Dengue is a rapidly emerging pandemic disease in many parts of the world, especially in Bangladesh. There is no accurate treatment to treat dengue patients. However, more illness and death could be prevented if countries regularly monitor the circulation of viruses in the mosquitos and take control measures before there are consequential outbreaks.
Cogan JE. Dengue and severe dengue. WHO. World Health Organization. 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/. Accessed on 3 June 2022.
Heilman JM, De Wolff J, Beards GM, Basden BJ. Dengue fever: a Wikipedia clinical review. Open Med. 2014;8(4):e105.
Tiga-Loza DC, Martínez-Vega RA, Undurraga EA, Tschampl CA, Shepard DS, Ramos-Castañeda J. Persistence of symptoms in dengue patients: a clinical cohort study. Transactions Royal Soci Trop Med Hygiene. 2020;114(5):355-64.
Verhagen LM, de Groot R. Dengue in children. J Infect. 2014;69:S77-86.
Siqueira Jr JB, Martelli CM, Coelho GE, da Rocha Simplício AC, Hatch DL. Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerging Infect Dis. 2005;11(1):48.
Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med. 2011;12(1):90-100.
Hossain MS, Hasan MM, Islam MS, Islam S, Mozaffor M, Khan MA et al. Chikungunya outbreak in Bangladesh: Clinical profile, economic impact and quality of life during the acute phase of the disease. PLoS Neglected Trop Dis. 2018;12(6):e0006561.
Dhar-Chowdhury P, Paul KK, Haque CE, Hossain S, Lindsay LR, Dibernardo A et al. Dengue seroprevalence, seroconversion and risk factors in Dhaka, Bangladesh. PLoS Neglected Trop Dis. 2017;11(3):e0005475.
Hossain MS, Amin R, Mosabbir AA. COVID-19 onslaught is masking the 2021 dengue outbreak in Dhaka, Bangladesh. PLoS Neglected Trop Dis. 2022;16(1):e0010130.
Hasan MJ, Tabassum T, Sharif M, Khan MA, Bipasha AR, Basher A, Islam MR, Amin MR, Gozal D. Clinico-epidemiologic characteristics of the 2019 dengue outbreak in Bangladesh. Transactions Royal Soci Trop Med Hygiene. 2021;115(7):733-40.
Mutsuddy P, Tahmina Jhora S, Shamsuzzaman AK, Kaisar SM, Khan MN. Dengue situation in Bangladesh: An epidemiological shift in terms of morbidity and mortality. Can J Infect Dis Med Microbiol. 2019;2019.
Kularatne SA. Dengue fever. BMJ. 2015;351.
National guideline for clinical management of dengue syndrome. 4th ed. Dhaka: Government of the People’s Republic of Bangladesh. 2018;1-87. Available at: https://dghs.gov.bd/images/docs/Guideline/National%20Guidelinee%20for%20Clinical%20Management%20of%20Dengue%20Syn drome%202018.pdf. Accessed on 24 May, 2022.
Hasan MJ, Tabassum T, Sharif M, Khan M, Saeed A, Bipasha AR, Basher A, Islam MR, Amin MR. Comparison of clinical manifestation of dengue fever in Bangladesh: an observation over a decade. BMC Infect Dis. 2021;21(1):1-0.
Mahmood R, Benzadid MS, Weston S, Hossain A, Ahmed T, Mitra DK, Ahmed S. Dengue outbreak 2019: clinical and laboratory profiles of dengue virus infection in Dhaka city. Heliyon. 2021;7(6):e07183.
World Health Organization. 1997. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. Available at: https://apps.who.int/iris/handle/10665/41988. Accessed on 06 June, 2022.
Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ. The WHO dengue classification and case definitions: time for a reassessment. Lancet. 2006;368(9530):170-3.
Mone FH, Hossain S, Hasan MT, Tajkia G, Ahmed F. Sustainable actions needed to mitigate dengue outbreak in Bangladesh. Lancet Infect Dis. 2019;19:1166-7.
Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27(1):1-13.
Ahsan A, Haider N, Kock R, Benfeld C. Possible drivers of the 2019 dengue outbreak in Bangladesh: the need for a robust community-level surveillance system. J Med Entomol. 2021;58(1):37-9.
Mobarak MR, Islam MR, Bhuiyan AT, Akand N, Begum F. Evaluation of Dengue Fever in a tertiary care children hospital of Bangladesh. Northern Int Med College J. 2017;9(1):274-7.